The Use of HAART Is Associated With Decreased Risk of Death During Initial Treatment of Cryptococcal Meningitis in Adults in Botswana
Journal of Acquired Immune Deficiency Syndromes - United States
doi 10.1097/qai.0b013e318183181e
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2008
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)